RELIEF THERAPEUTICS HOLDING SA Research and Development Expense
RELIEF THERAPEUTICS HOLDING SA (MMTZF) reported Research and Development Expense of CHF 1.33 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2024-04-30
| Period end | Research And Development Expense 12 month |
|---|---|
| 2023-12-31 | 1.33M CHF 20-F · filed 2024-04-30 |
| 2022-12-31 | 12.39M CHF 20-F · filed 2024-04-30 |
| 2021-12-31 | 19.02M CHF 20-F · filed 2023-05-12 |